CAH Wait before going long as both Technical and Fundamental might suggest to go long.
Fundamental Analysis: The drug distributor reported quarterly earnings of $1.62 per share, beating the consensus estimate of $1.43 a share. Revenue also beat forecasts
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.